Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04927338 · ClinicalTrials.gov registry record · Phase 2
Study of Bacopa in Gulf War Illness Patients
A Phase 2 study of Gulf War Illness, sponsored by Nova Southeastern University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 170
- Enrollment target
- 1
- Study location
NCT04927338 is a Phase 2 study of Gulf War Illness that is actively recruiting participants, run by Nova Southeastern University. The registered enrollment target is 170 participants, above the 118-participant average among 14 other Gulf War Illness trials with a reported enrollment target (44% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04927338, a Phase 2 study of Gulf War Illness, is actively recruiting participants, sponsored by Nova Southeastern University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 170 participants
- Enrollment target
- 1
- Study location
Study Summary
Gulf War Illness is a condition that affects multiple major organ systems, resulting in a diverse array of symptoms that include debilitating fatigue, memory and cognition difficulties, headaches, sleep disturbances, gastrointestinal problems, skin rashes, and musculoskeletal/joint pain. This phase II, double masked, randomized, placebo-controlled, two-arm study will evaluate cognitive function as evidence of efficacy of the nutraceutical intervention, Bacopa, on central nervous system symptom management of Gulf War Illness, along with assessments of safety of the intervention.
Conditions Studied
Interventions
- DRUG Placebo
- DIETARY_SUPPLEMENT BacoMind® (Bacopa monnieri standardized extract)
Study Locations (1)
Florida
- Nova Southeastern University - Davie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2022-12-01 |
| Est. Completion | 2026-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04927338
The ClinicalTrials.gov registry entry for NCT04927338 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 118-participant average among 14 other Gulf War Illness trials with a reported enrollment target (44% higher). The listed sponsor is Nova Southeastern University, which has 71 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gulf War Illness appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04927338 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04927338 about?
NCT04927338 is a clinical study titled "Study of Bacopa in Gulf War Illness Patients". Gulf War Illness is a condition that affects multiple major organ systems, resulting in a diverse array of symptoms that include debilitating fatigue, memory and cognition difficulties, headaches, sleep disturbances, gastrointestinal problems, skin rashes, and musculoskeletal/joint pain. This phase ...
What is the current status of trial NCT04927338?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 170 participants. The study started on 2022-12-01. Estimated completion is 2026-04.
What conditions does trial NCT04927338 study?
This clinical trial studies the following conditions: Gulf War Illness.
What interventions are being tested in trial NCT04927338?
The interventions under investigation include: Placebo (DRUG), BacoMind® (Bacopa monnieri standardized extract) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04927338?
This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04927338 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gulf War Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ca-Mg Butyrate in GWI
RECRUITING · Phase 2
-
Resistant Potato Starch to Alleviate GWI
RECRUITING · Phase 2
-
Confirmation of Diet as a Treatment for Gulf War Illness
RECRUITING · Phase 3
-
NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)
RECRUITING
-
Validating Gulf War Illness Blood Biomarkers
RECRUITING
-
Nicotinamide Riboside Clinical Trial for GWI
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.